Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -258,478 | -192,744 | -94,239 | -290,509 | -223,006 |
| Depreciation Amortization | -3,200 | -1,687 | -820 | 5,312 | 4,531 |
| Accounts receivable | 95 | 228 | 20 | 97 | 162 |
| Accounts payable and accrued liabilities | 2,980 | 4,202 | 1,400 | N/A | 22 |
| Other Working Capital | -11,859 | 16,926 | 7,414 | 11,246 | 4,876 |
| Other Operating Activity | 59,334 | 37,344 | 19,095 | 44,364 | 41,004 |
| Operating Cash Flow | $-211,128 | $-135,731 | $-67,130 | $-229,490 | $-172,411 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 450,691 | 293,984 | 175,044 | 355,736 | 172,715 |
| PPE Investments | -4,008 | -3,418 | -1,915 | -9,062 | -6,746 |
| Purchase Of Investment | -248,727 | -163,975 | -97,815 | -535,419 | -207,778 |
| Investing Cash Flow | $197,956 | $126,591 | $75,314 | $-188,745 | $-41,809 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,835 | 3,377 | 1,297 | 289,910 | 288,744 |
| Financing Cash Flow | $12,835 | $3,377 | $1,297 | $289,910 | $288,744 |
| Beginning Cash Position | 154,372 | 154,372 | 154,372 | 282,697 | 282,697 |
| End Cash Position | 154,035 | 148,609 | 163,853 | 154,372 | 357,221 |
| Net Cash Flow | $-337 | $-5,763 | $9,481 | $-128,325 | $74,524 |
| Free Cash Flow | |||||
| Operating Cash Flow | -211,128 | -135,731 | -67,130 | -229,490 | -172,411 |
| Capital Expenditure | -4,008 | -3,418 | -1,915 | -9,062 | -6,746 |
| Free Cash Flow | -215,136 | -139,149 | -69,045 | -238,552 | -179,157 |